Thomas G. Wiggans is a businessperson who founded Dermira, Inc. and who has been at the head of 9 different companies. Mr. Wiggans holds the position of Chairman for Annexon, Inc., Executive Chairman of Follica, Inc. and Chairman & Chief Executive Officer of Pardes Biosciences, Inc. Thomas G. Wiggans is also Chairman for The Biotechnology Institute and on the board of 8 other companies.

In his past career he was Principal at Eli Lilly & Co. and Chairman & Chief Executive Officer of Dermira, Inc. (a subsidiary of Eli Lilly & Co.), President-US Pharmaceutical Operations at Ares-Serono Group, Chairman & Chief Executive Officer at Connetics Corp., Chairman & Chief Executive Officer at Peplin, Inc., Chairman for Excaliard Pharmaceuticals, Inc. and President & Chief Operating Officer for CytoTherapuetics, Inc.

He received an undergraduate degree from the University of Kansas and an MBA from Southern Methodist University.